Figure 2
From: The immunomodulatory role of paracrine signalling factor VSIG4 in peritoneal metastases
Kaplan–Meier (KM) survival curves illustrating (A) better prognosis in patients with high stromal VSIG4 (n = 205, p = 0.0226) and (B) no significant association between tumour VSIG4 and survival rate (n = 211, p = 0.507).
